EN DE

Ventas Inc (VTR) Fair Value & Analysis

Real Estate · US · Market cap $42.1B · ISIN US92276F1003

What is Ventas Inc really worth?

VI Ventas Inc logo Ventas Inc VTR · US
Price$92.11
Fair Value$15.22
Upside−83.5%
Quality40/100

Structural break: The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.

Below-average quality, and trading another 505% above our fair value of $15.22.

Watch Ventas Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

Moderate debt · generates free cash flow

Risks

!Mixed Growth (revenue 5y +9.0 %/yr)
!Thin margins · 4.3% net margin
!Trails peers (2/15)
!Narrow moat 32/100
!Evidence only low, so the estimate is less certain
!Weak on past: 9 out of 100

For context

·2.13% dividend yield
Evidence: Low Range $10.03 – $15.22

Fair value as of: Aug 13, 2026

From 16 valuation models · updated 22 days ago

Share price +1.4% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits above even our optimistic bull case ($15.22). The favourable scenario is already priced in.
  • Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Price vs Fair Value (5 years)

$100.53 $32.05 Fair Value $15.22 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $32.05 – $100.53 · fair‑value band $10.03 – $15.22 · the $92.11 price screens above the $15.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ventas Inc (VTR) currently trades at $92.11, while our model-based Fair Value estimate is $15.22, implying the stock looks roughly 505.0% overvalued today. The Quality Score stands at 40/100 (below-average quality), in the Real Estate sector. Bull case: the DCF Models group reads highest at a median of $34.91 per share, and 0 of the 15 models we run sit above the $92.11 price. Bear case: the Growth DCF group reads lowest at $8.63, and 15 of the 15 models stay below the price. Evidence for this calculation is low.

Over the trailing twelve months, Ventas Inc generated revenue of $6.1B at a net margin of 4.3%. Revenue grew 21.9% year over year. It earns a return on equity of 2.1%. Net debt stands at $12.5B. Fundamentals as of Aug 13, 2026

Our scenario range runs from $10.03 (bear case) to $15.22 (bull case); at $92.11, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 52% above its 52-week low, currently above its 200-day average. For context, the median of 10 Real Estate peers we cover trades at −47% fair-value upside, at −83%, VTR screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income best evidence $18.28 $17.64 $14.08 76
FCF DCF $8.89 $34.91 $79.14 72
5Y EBITDA Exit $20.07 $57.13 $103.30 71
All 16 models by family
DCF Models
FCF DCF $8.89 $34.91 $79.14 72
5Y Revenue Exit $8.58 $24.83 69
5Y EBITDA Exit $20.07 $57.13 $103.30 71
10Y Revenue Exit $12.81 $31.66 64
10Y EBITDA Exit $15.96 $48.04 $96.28 63
Dividend Discount
Gordon GGM $16.24 $33.77 $53.58 66
DDM Multi-Stage $16.24 $28.48 $35.45 66
Multiples
P/S Multiple $6.59 $8.79 $10.99 58
P/B Multiple $6.59 $8.79 $10.99 55
EV/EBIT $2.82 $12.18 $21.53 59
EV/EBITDA $30.09 $48.53 $66.98 66
EV/Revenue $3.50 50
Asset-Based
NCAV (Graham) $12.88 $17.26 $25.77 54
Growth DCF
Growth DCF $8.79 $33.08 $73.54 71
Rev-Margin DCF $8.63 $24.54 69
Economic Profit
Residual Income best evidence $18.28 $17.64 $14.08 76

Widest divergence: DCF Models ($34.91) versus Growth DCF ($8.63). Highest evidence: Residual Income (76).

Notify me when VTR reaches fair value

Put VTR on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 167.5
P/S ratio 7.22 P/E × margin
EPS (TTM) $0.5500 price ÷ EPS = P/E 167.5
Dividend yield 2.1%
Net margin 4.3% FY2025
Return on equity 2.1% TTM
More key figures
Profitability
Return on assets (EBIT) 2.2% avg 5y
Operating margin 13.8% TTM
Growth
Revenue (TTM) $6.1B TTM
Revenue growth (YoY) +21.9% 3y avg +12.2%
EPS growth (YoY) +10.0%
Balance sheet & cash flow
Free cash flow $1.3B FY2025
Net debt $12.5B FY2025 · ≈ 9.5 yrs of FCF

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 40/100

Of which business quality 43 · Market factors (momentum, volatility) 77

Profitability 15
Margins and returns on capital today
Quality Growth 47
Are margins and returns improving?
Cashflow 90
Earnings quality: real cash, not paper profit
Fin. Strength 33
Balance sheet, leverage, solvency risk
Investment 73
Disciplined investing over empire-building
Low Volatility 83
Calm price path (market factor)
Momentum 66
Price trend over the last 3–12 months (market factor)
52W Momentum 89
Distance to the 52-week high (market factor)
Net Issuance 2
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy.

Full company description

Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives. Ventas, Inc. was incorporated in 1983 and is based in Chicago, United States.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Ventas Inc reported revenue of $5.8B in FY2025 versus $3.8B in FY2021, a compound +11.1%/yr. Reported net income was $251M in FY2025, compounding +50.5%/yr from FY2021.

Growth Quality 78/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$5.8B
Latest YoY
+18.5%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+12.2%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.0%
Avg. revenue growth/yr (30Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.1%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
−12.1% (−14.2 + 2.1)
Revenue +11.1%/yr
FY21 $3.8B
FY22 $4.1B
FY23 $4.5B
FY24 $4.9B
FY25 $5.8B
Net income +50.5%/yr
FY21 $49.0M
FY22 −$47.4M
FY23 −$41.0M
FY24 $81.2M
FY25 $251M

VTR screens 505% overvalued. Compare with Welltower Inc →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Ventas Inc Fair Value". https://www.fairvalue-calculator.com/stock/VTR

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

REIT - Healthcare Facilities · 25 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 41 · Bottom 25%
Fair Value upside −84% · Bottom 25%
Return on equity (TTM) 2% · Below median
Return on assets 2% · Below median
Net margin (TTM) 4% · Below median
Operating margin (TTM) 14% · Bottom 25%
Revenue growth 22% · Top 25%
Dividend yield (TTM) 2.1% · Bottom 25%
Debt / equity 1.04× · Higher than 75% of peers

Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper

P/E (TTM) 167.5× · Pricier than 75% of peers
P/B 3.36× · Pricier than 75% of peers
P/S (TTM) 6.89× · Pricier than median
P/FCF 32.0× · Pricier than 75% of peers
EV/EBITDA 23.8× · Pricier than 75% of peers
PEG 1.74× · Cheaper than 75% of peers

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 6
FUTURE100 · sector 36
PAST9 · sector 23
HEALTH48 · sector 73
DIVIDEND43 · sector 100

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Welltower Inc WELL $238.07 $41.85 −82%
Omega Healthcare Investors, Inc OHI $45.99 $29.19 −37%
Healthpeak Properties, Inc DOC $21.40 $6.95 −68%
American Healthcare REIT, Inc AHR $56.19 $10.94 −81%
CareTrust REIT, Inc CTRE $39.61 $22.79 −42%
Healthcare Realty Trust Incorporated HR $19.39 $20.60 +6%
Aedifica NV AED €66.55 €34.97 −47%
Chartwell Retirement Residences CSHUN C$21.17 C$3.49 −84%
Sabra Health Care REIT, Inc SBRA $20.39 $10.49 −49%
National Health Investors, Inc NHI $72.27 $64.82 −10%

Compare Ventas Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Ventas Inc (VTR) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $15.22 versus a price of $92.11, about −83% upside (overvalued).
What is the fair value of VTR?
Our model-based fair value for Ventas Inc is $15.22 (as of Aug 13, 2026), built from audited fundamentals. The current price: $92.11.
What is the quality score of VTR?
Ventas Inc has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Ventas Inc (VTR)?
Ventas Inc reported trailing-twelve-month revenue of about $6.1B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of VTR?
The net profit margin of Ventas Inc is about 4.3%, meaning it keeps roughly 4.3% of revenue as net income. Based on the latest reported figures.
Does Ventas Inc pay a dividend?
Ventas Inc currently shows a dividend yield of about 2.13% relative to its recent price (as of Aug 13, 2026).
Free · no account needed

Watch Ventas Inc in the live analysis

One click puts Ventas Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.